Evidence map›Paper›PMID 40691332›Full record

ArticleSurgical endoscopy2025

Identification of postoperative complications in sigmoid colon cancer and rectal cancer using the C-reactive protein level.

Taro Munechika, Gumpei Yoshimatsu, Takayuki Akasaki, Keiichi Shiokawa, Issei Takeshita, Hisaaki Shimokobe, Kurumi Sahara, Yoshiko Matsumoto, Hideki Nagano, Ken Nagata and 2 more

Abstract read
PubMed Publisher
In one paragraph

Article in Surgical endoscopy, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors.

Taro MunechikaDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan.
Gumpei YoshimatsuDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan. gyoshimatsu@fukuoka-u.ac.jp.ORCID http://orcid.org/0000-0001-6559-5947
Takayuki AkasakiDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan.
Keiichi ShiokawaDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan.
Issei TakeshitaDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan.
Hisaaki ShimokobeDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan.
Kurumi SaharaDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan.
Yoshiko MatsumotoDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan.
Hideki NaganoDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan.
Ken NagataDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan.
Naoya AisuDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan.
Suguru HasegawaDepartment of Surgery, Fukuoka University Hospital, 7-45-1 Nanakuma, Jonan-Ku, Fukuoka, Fukuoka, 814-0180, Japan.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundPostoperative 'surgery-associated' complications may require reoperation, so early detection and treatment are crucial. However, the decision to perform additional tests for a definitive diagnosis often relies on the surgeon's experience rather than objective criteria. The C-reactive protein (CRP) level is widely used as an indicator of acute-phase inflammation but also increases in response to surgical stress. Therefore, it is difficult to distinguish complications based solely on the CRP level. In this study, we examined the ability of the CRP level to predict complications after left-sided colorectal cancer surgery when patients are categorized according to day of onset of complications.

methodsThis study includes a substantial proportion of patients undergoing robot-assisted surgery, differentiating it from previous studies. First, we performed linear regression analysis to create a predictive model for CRP levels during a normal postoperative course using the CRP level before surgery and on postoperative days (PODs) 1, 3, 5, and 7 from patients without complications. Next, we calculated the difference between the measured and predicted CRP values for all patients and investigated the correlation between these deviations and the occurrence of surgical complications on the day of CRP measurement or the following day.

resultsAmong 498 patients, forty-seven patients developed complications including 25 patients with surgical complications. When the CRP level measured on POD1 was ≥ 12.1 mg/dL and the deviation from the predicted value was ≥  + 6.7 mg/dL, the incidence of surgical complications was significantly higher. Similarly, on POD3, a measured CRP level of ≥ 10.8 mg/dL and a deviation of ≥  + 4.14 mg/dL were significantly associated with an increased incidence of surgical complications.

conclusionThe deviation between CRP levels measured on POD1 and POD3 from those in patients with a normal postoperative course after surgery for left-sided colorectal cancer is useful for identifying imminent surgical complications.

Indexed as

C-Reactive ProteinPostoperative ComplicationsRectal NeoplasmsSigmoid NeoplasmsAgedAged, 80 and overColectomyFemaleHumansMaleMiddle AgedPredictive Value of TestsRetrospective StudiesRobotic Surgical ProceduresC-Reactive ProteinCRPPostoperative complicationRectal cancerSigmoid colon cancer

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.